Related Experiment Video
Updated: May 23, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Management of HIV in the pregnant woman
1Division of Infectious Diseases, The Ohio State University, Columbus, Ohio, USA. john.davis@osumc.edu
Abstract:
The treatment of human immunodeficiency virus (HIV)-infected pregnant women is one of the most effective HIV-prevention interventions known. With prenatal testing, antiviral therapy, scheduled cesarean section when indicated, and formula feeding when feasible, rates of neonatal and perinatal HIV infection can diminish significantly. Although significant prevention is achievable, new cases of HIV in neonates continue to occur both worldwide and locally due to limited resources, delayed diagnosis, lack of linkage to care, and lack of timely effective therapy. Where those resources are available, the management of HIV infection in the pregnant woman requires a multidisciplinary expert approach to achieve optimal outcomes for both mother and child.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Mitral Valve Prolapse III: Nursing Management
Cytomegalovirus Disease
Pharmacokinetics in Pediatric Patients: Drug Excretion
Rh Blood Group

